Dual alterations in casein kinase I-ε and GSK-3β modulate β-catenin stability in hyperproliferating colonic epithelia

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 292, Issue 2, 2007, Pages

  Umar, Shahid ^a   Wang, Yu ^a   Morris, Andrew P ^b   Sellin, Joseph H ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Colon; Hyperproliferation

Indexed keywords

AXIN; BETA CATENIN; CASEIN KINASE IEPSILON; CELL PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOSKELETON PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; NUCLEAR PROTEIN; PROTEASOME; PROTEIN KINASE C DELTA; SERINE; T CELL FACTOR 4 PROTEIN; THREONINE; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CITROBACTER RODENTIUM; COLON MUCOSA; CONTROLLED STUDY; CRYPT CELL; CYTOSKELETON; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HYPERPLASIA; IMMUNOPRECIPITATION; IN VIVO STUDY; INTESTINE CRYPT; MOUSE; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN TRANSPORT; STEADY STATE;

ANIMALS; BETA CATENIN; BORONIC ACIDS; CASEIN KINASE IEPSILON; CELL NUCLEUS; CITROBACTER RODENTIUM; COLON; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYTOSKELETON; DNA; ENTEROBACTERIACEAE INFECTIONS; GLYCOGEN SYNTHASE KINASE 3; HYPERPLASIA; IMMUNOPRECIPITATION; INTESTINAL MUCOSA; MICE; PHOSPHORYLATION; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN KINASE C; PYRAZINES; REPRESSOR PROTEINS; SERINE; TCF TRANSCRIPTION FACTORS; THREONINE;

EID: 33847008637     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00343.2006     Document Type: Article

References (43)

1. Amit S, Hatzubai A, Birman Y, Andersen S, Ben-Shushan E, Mann M, Ben-Neriah Y, Alkalay I. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev 16: 1066-1076, 2002.
2. Barthold SW, Coleman GL, Bhatt PN, Osbaldiston GW, Jonas AM. The etiology of transmissible murine colonic hyperplasia. Lab Anim Sci 26: 889-894, 1976.
3. Cadigan K, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev 11: 3286-3305, 1997.
4. Cegielska A, Gietzen KF, Rivers A, Virshup DM. Autoinhibition of casein kinase I epsilon (CKI epsilon) is relieved by protein phosphatases and limited proteolysis. J Biol Chem 273: 1357-1364, 1998.
5. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789, 1995.
6. Dajani R, Fraser E, Roe S, Young N, Good V, Dale T, Pearl L. Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105: 721-732, 2001.
7. Ding VW, Chen RH, McCormick F. Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling. J Biol Chem 275: 32475-32481, 2000.
8. Frame S, Cohen P, Biondi M. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell 7: 1321-1327, 2001.
9. Gao ZH, Seeling JM, Hill A, Yochum A, Virshup DM. Casein kinase I phosphorylates and destabilizes the beta-catenin degradation complex. Proc Natl Acad Sci USA 99: 1182-1187, 2002.
10. Goodenough S, Conrad S, Skutella T, Behl C. Inactivation of glycogen synthase kinase-3beta protects against kainic acid-induced neurotoxicity in vivo. Brain Res 1026: 116-125, 2004.
11. Hajra KM, Fearon ER. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 34: 255-268, 2002.
12. Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H, Perret C, Rubinfeld B, Margottin F, Benarous R, Polakis P. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 9: 207-210, 1999.
13. Hecht A, Vleminckx K, Stemmler MP, van Roy F, Kemler R. The p300/CBP acetyl-transferases function as transcriptional coactivators of beta-catenin in vertebrates. EMBO J 19: 1839-1850, 2000.
14. Kang DE, Soriano S, Xia X, Eberhart C, De Strooper B, Zheng H, Koo EH. Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis. Cell 110: 751-762, 2002.
15. Kanzaki M, Mora S, Hwang JB, Saltiel AR, Pessin JE. Atypical protein kinase C (PKCζ/λ) is a convergent downstream target of the insulin-stimulated phosphatidylinositol 3-kinase and TC10 signaling pathways. J Cell Biol 64, 279-290, 2004.
16. Kitagawa M, Hatakeyama S, Shirane M, Matsumoto M, Ishida N, Hattori K, Nakamichi I, Kikuchi A, Nakayama K, Nakayama K. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J 18: 2401-2410, 1999.
17. Lévy L, Wei Y, Labalette C, Wu Y, Renard CA, Buendia MA, Neuveut C. Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction. Mol Cell Biol 24: 3404-3414, 2004.
18. Liu C, Li Y, Semenov M, Han C, Baeg G, Tan Y, Zhang Z, Lin X, He X. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108: 837-847, 2002.
19. McKay RM, Peters JM, Graff JM. The casein kinase I family: roles in morphogenesis. Dev Biol 235: 378-387, 2001.
20. McKay RM, Peters JM, Graff JM. The casein kinase I family in Wnt signaling. Dev Biol 235: 388-396, 2001.
21. Min/-+ mice. J Infect Dis 184: 227-230, 2001.
22. Oriente F, Formisano P, Miele C, Fiory F, Maitan MA, Vigliotta G, Trencia A, Santopietro S, Caruso M, Van Obberghen E, Beguinot F. Insulin receptor substrate-2 phosphorylation is necessary for protein kinase C zeta activation by insulin in L6hIR cells. J Biol Chem 276: 37109-37119, 2001.
23. Pap M, Cooper GM. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 273: 19929-19932, 1998.
24. Patel S, Doble B, Woodgett JR. Glycogen synthase kinase-3 in insulin and Wnt signaling: a double-edged sword? Biochem Soc Trans 32: 803-808, 2004.
25. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 287: 1606-1609, 2000.
26. Peters JM, McKay RM, McKay JP, Graff JM. Casein kinase I transduces Wnt signals. Nature 401: 345-350, 1999.
27. Polakis P. Wnt signaling and cancer. Genes Dev 14: 1837-1851, 2000.
28. Rivers A, Gietzen KF, Vielhaber E, Virshup DM. Regulation of casein kinase I epsilon and casein kinase I delta by an in vivo futile phosphorylation cycle. J Biol Chem 273: 15980-15984, 1998.
29. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 275: 1790-1792, 1997.
30. Sadot E, Conacci-Sorrell M, Zhurinsky J, Shnizer D, Lando Z, Zharhary D, Kam Z, Ben-Ze'ev A, Geiger B. Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells. J Cell Sci 115: 2771-2780, 2002.
31. Sakanaka C. Phosphorylation and regulation of beta-catenin by casein kinase I epsilon. J Biochem (Tokyo) 132: 697-703, 2002.
32. Sakanaka C, Leong P, Xu L, Harrison SD, Williams LT. Casein kinase I epsilon in the Wnt pathway: regulation of beta-catenin function. Proc Natl Acad Sci USA 96: 12548-12552, 1999.
33. Sellin JH, Umar S, Xiao J, Morris AP. Increased beta-catenin expression and nuclear translocation accompany cellular hyperproliferation in vivo. Cancer Res 61: 2899-2906, 2001.
34. Sutherland C, Leighton IA, Cohen P. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signaling. Biochem J 296: 15-19, 1993.
35. Swiatek W, Tsai I-C, Klimowski L, Pepler A, Barnette J, Yost HJ, Virshup DM. Regulation of casein kinase Iε activity by Wnt signaling. J Biol Chem 279: 13011-13017, 2004.
36. Umar S, Morris AP, Kourouma F, Sellin JH. Dietary pectin and calcium inhibit colonic proliferation in vivo by differing mechanisms. Cell Prolif 36: 361-375, 2003.
37. - secretion. Am J Physiol Gastrointest Liver Physiol 278: G753-G764, 2000.
38. Umar S, Sellin JH, Morris AP. Murine colonic mucosa hyperproliferation. II. PKC-β activation and cPKC-mediated cellular CFTR overexpression. Am J Physiol Gastrointest Liver Physiol 278: G765-G774, 2000.
39. Umar S, Sellin JH, Morris AP. Increased nuclear translocation of catalytically active PKC-ζ during mouse colonocyte hyperproliferation. Am J Physiol Gastrointest Liver Physiol 279: G223-G237, 2000.
40. Umar S, Wang Y, Sellin JH. Epithelial proliferation induces novel changes in APC expression. Oncogene 24: 6709-6718, 2005.
41. Wolf D, Rodova M, Miska EA, Calvet JP, Kouzarides T. Acetylation of beta-catenin by CREB-binding protein (CBP). J Biol Chem 277: 25562-25567, 2002.
42. Yuan H, Mao J, Li L, Wu D. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation. J Biol Chem 274: 30419-30423, 1999.
43. Zhang DE, Hoyt PR, Papacostantinou J. Localization of DNA protein-binding sites in the proximal and distal promoter regions of the mouse alpha-fetoprotein gene. J Biol Chem 265: 3382-3391, 1990.